Article
Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.
Gynecologic oncology - 1 Mar 2024
Casanova Joao, Duarte Gonçalo Silva, da Costa Ana Gomes, Catarino Ana, Nave Mónica, Antunes Telma, Serra Sofia Silvério, Dias Sara Simões, Abu-Rustum Nadeem, Lima Jorge
Abstract excerpt
BACKGROUND: POLE mutated endometrial carcinomas may represent a subspecific type of tumors harboring a more favorable prognosis. Grade 3 (G3 or high-grade) endometrioid endometrial carcinomas remain a clinical dilemma, with some tumors behaving as the low-grade counterparts and others presenting a more aggressive behavior. OBJECTIVES: To determine the association between POLE mutational status and the...
Topics
- Female
- Humans
- Carcinoma, Endometrioid
- DNA Polymerase II
- Endometrial Neoplasms
- Mutation
- Neoplasm Grading
- Poly-ADP-Ribose Binding Proteins
- Prognosis
- Progression-Free Survival
